Nuview Life Sciences Is A Clinical Stage Precision Oncology Companythe Vasoactive Intestinal Peptide Pituitary Adenylate Cyclase Activating Peptide Receptor Is Over Expressed On The Surface Of A Wide Range Of Cancer Types At The Onset Of Oncogenesis Nuview Snv Vpac1 Small Molecule Binding Agent Designed To Identify And Bind To The Vpac Receptors Has Been Utilized In Clinical Trials For Binary In Vitro And In Vivo Confirmation Of Cancer The Nv Vpac1 Agent Can Deliver Existing Therapeutics And New Alpha And Beta Emittersnuview Will Pair Existing Imaging And Therapeutic Radionuclides With Nuviews Proprietary Agent And Provide A Theranostics Solution For Patients And Clinicians
No conferences found for this company.
| Company Name | Nuview Life Sciences Inc |
| Country |
United States
|
| Address | 1389 Center Dr 250 Park City Ut 84098 Usa |
| Telephone | Login to View |
| Login to View |
